Q3 2025 Earnings Call November 6, 2025 8:00 AM ESTCompany ParticipantsAndrew Barnett - Head of Investor RelationsPascal Soriot - ...
UNC School of Medicine researchers have led an international clinical trial of patients with generalized myasthenia gravis, ...
A new option is now approved to treat adults living with high-risk smoldering multiple myeloma. 1 The FDA has greenlit ...
The regimen of bexmarilimab and azacitidine (Vidaza) demonstrated a highly promising efficacy profile with a manageable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback